- Home
- HTBK vs DNTH Comparison
HTBK vs DNTH Comparison
Compare HTBK & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTBK
- DNTH
- Stock Information
- Founded
- HTBK 1997
- DNTH 2015
- Country
- HTBK United States
- DNTH United States
- Employees
- HTBK N/A
- DNTH N/A
- Industry
- HTBK Major Banks
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- HTBK Finance
- DNTH Health Care
- Exchange
- HTBK Nasdaq
- DNTH Nasdaq
- Market Cap
- HTBK 588.2M
- DNTH 606.2M
- IPO Year
- HTBK 1998
- DNTH N/A
- Fundamental
- Price
- HTBK $10.40
- DNTH $19.94
- Analyst Decision
- HTBK Buy
- DNTH Strong Buy
- Analyst Count
- HTBK 3
- DNTH 8
- Target Price
- HTBK $11.33
- DNTH $53.00
- AVG Volume (30 Days)
- HTBK 476.2K
- DNTH 374.8K
- Earning Date
- HTBK 07-24-2025
- DNTH 08-07-2025
- Dividend Yield
- HTBK 5.01%
- DNTH N/A
- EPS Growth
- HTBK N/A
- DNTH N/A
- EPS
- HTBK 0.68
- DNTH N/A
- Revenue
- HTBK $174,083,000.00
- DNTH $6,524,000.00
- Revenue This Year
- HTBK $7.71
- DNTH N/A
- Revenue Next Year
- HTBK $6.13
- DNTH N/A
- P/E Ratio
- HTBK $15.25
- DNTH N/A
- Revenue Growth
- HTBK N/A
- DNTH 102.36
- 52 Week Low
- HTBK $8.09
- DNTH $13.37
- 52 Week High
- HTBK $11.27
- DNTH $32.27
- Technical
- Relative Strength Index (RSI)
- HTBK 66.25
- DNTH 57.13
- Support Level
- HTBK $10.41
- DNTH $17.88
- Resistance Level
- HTBK $10.77
- DNTH $23.37
- Average True Range (ATR)
- HTBK 0.23
- DNTH 1.35
- MACD
- HTBK 0.05
- DNTH 0.31
- Stochastic Oscillator
- HTBK 75.00
- DNTH 48.96
About HTBK Heritage Commerce Corp
Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.